Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2026-01-21 @ 2:21 AM
Study NCT ID:
NCT03447132
Status:
COMPLETED
Last Update Posted:
2023-03-10
First Post:
2018-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant
Sponsor:
International Cancer Research Group, United Arab Emirates
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ICRG1201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None